BIOSYNEX (ALBIO.PA) Stock Analyst Earnings Estimates
EPA:ALBIO - Euronext Paris - Matif - FR0011005933 - Common Stock - Currency: EUR
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | ||
|---|---|---|---|---|---|
| Revenue YoY % growth | 196.6M -48.60% | 92.978M -52.71% | 101.167M 8.81% | 146.47M 44.78% | |
| EBITDA YoY % growth | 65.7M -53.93% | -23.945M -136.45% | -15.799M 34.02% | 14.317M 190.62% | |
| EBIT YoY % growth | 38.8M -72.40% | -37.404M -196.40% | -36.333M 2.86% | 5.974M 116.44% | |
| Operating Margin | 19.74% | -40.23% | -35.91% | 4.08% | |
| EPS YoY % growth | N/A | N/A | N/A 103.92% | 0.47 475.00% |
All data in EUR
| EPS Q2Q % growth |
|---|
| Revenue Q2Q % growth |
| EBITDA Q2Q % growth |
| EBIT Q2Q % growth |
All data in EUR
| Period | Reported | Estimate | Difference | Surprise |
|---|
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q4 2024 Q2Q % growth | 47.426M -5.76% | % | ||
| Q2 2024 Q2Q % growth | 53.7M 25.90% | % | ||
| Q4 2023 Q2Q % growth | 50.325M -7.32% | % | ||
| Q2 2023 Q2Q % growth | 42.653M -70.00% | % | ||
| Q4 2022 Q2Q % growth | 54.3M -65.48% | % | ||
| Q2 2022 Q2Q % growth | 142.2M -36.86% | % | ||
| Q4 2021 Q2Q % growth | 157.3M 43.26% | % | ||
| Q2 2021 Q2Q % growth | 225.2M 410.66% | % | ||
| Q4 2020 Q2Q % growth | 109.8M 557.49% | % | ||
| Q2 2020 Q2Q % growth | 44.1M 152.00% | % |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | N/A | N/A | 0% | 0% |
| Revenue | N/A | N/A | 0% | 0% |